{
  "id": "5a6f8baeb750ff4455000057",
  "type": "summary",
  "question": "What is the purpose of the FRAX scale?",
  "ideal_answer": "The FRAX score (The WHO Fracture Risk Assessment Tool), is a free web-based clinical scale assessing the 10-year probability of major osteoporotic fracture risk and need for lifestyle advice/reassurance, dual X-ray absorptiometry (DEXA) scanning or preventive treatment.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22630782",
    "http://www.ncbi.nlm.nih.gov/pubmed/22492479",
    "http://www.ncbi.nlm.nih.gov/pubmed/25771422",
    "http://www.ncbi.nlm.nih.gov/pubmed/22489911",
    "http://www.ncbi.nlm.nih.gov/pubmed/26474615",
    "http://www.ncbi.nlm.nih.gov/pubmed/24369275",
    "http://www.ncbi.nlm.nih.gov/pubmed/28004298",
    "http://www.ncbi.nlm.nih.gov/pubmed/27647529",
    "http://www.ncbi.nlm.nih.gov/pubmed/25186156",
    "http://www.ncbi.nlm.nih.gov/pubmed/21899835",
    "http://www.ncbi.nlm.nih.gov/pubmed/28660987",
    "http://www.ncbi.nlm.nih.gov/pubmed/23203733",
    "http://www.ncbi.nlm.nih.gov/pubmed/21198706",
    "http://www.ncbi.nlm.nih.gov/pubmed/28429557"
  ],
  "snippets": [
    {
      "text": "RESULTS: The DA was acceptable to subjects, but 17\u00a0% of the patients in the decision aid arm incorrectly entered their T-scores into FRAX-based risk calculator. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27647529",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Comparing self-perceived and estimated fracture risk by FRAX\u00ae of women with osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28004298",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In this study, we compared subjective fracture risks of Hungarian women with osteoporosis to FRAX\u00ae-based estimates. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28004298",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: The main objectives were to explore associations between self-perceived 10-year fracture risks of women with osteoporosis (OP) and their risks calculated by the FRAX\u00ae algorithm and to identify determinants of the underestimation of risk.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28004298",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The development of absolute fracture risk (AFR) algorithms, such as FRAX\u00ae and the Garvan absolute fracture risk calculator, to predict risk of fracture over a given time (usually 10\u00a0years) aims to incorporate non-BMD risk factors into the clinical assessment. FRAX\u00ae has been shown to be useful to assess fracture risk in CKD but may underestimate fracture risk in advanced CKD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28429557",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "THE GOAL: was an evaluation of the correlation between 10-year risk of death from CVD and 10-year bone fracture risk (FRAX).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28660987",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To verify the fracture risk assessment tool (FRAX) to estimate the probability of osteoporotic fracture in patients with rheumatoid arthritis (RA) with or without bone mineral density (BMD), and identify associated risk factors of osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26474615",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Can paramedics use FRAX (the WHO Fracture Risk Assessment Tool) to help GPs improve future fracture risk in patients who fall?",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25186156",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Paramedics who attend to patients who have fallen may be well placed to assess future fracture risk, using the Fracture Risk Assessment Tool (FRAX) and communicate that information directly to general practitioners (GPs).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25186156",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Key changes are revision of the criteria for initiation of pharmaceutical treatment, along with an introduction of the fracture risk factors used in FRAX\u00ae, inclusion of newly developed drugs, and revision of the recommendation grades for pharmaceutical treatment of osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24369275",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Fracture Risk Assessment Tool (FRAX) was developed to estimate the risk of fracture in the general population. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22489911",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "FRAX provides 10-year probability of major fractures.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22630782",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The WHO Fracture Risk Assessment Tool (FRAX; http://www.shef.ac.uk/FRAX) estimates the 10-year probability of major osteoporotic fracture. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22492479",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "One of the key changes is revision of the criteria for initiation of pharmacological treatment, along with an introduction of the fracture risk factors used in FRAX\u00ae. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23203733",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The principal variable was the likelihood of fracture evaluated with the FRAX\u00ae tool for the Spanish population.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21899835",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21198706",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "he FRAX score, developed by the WHO, is a free web-based clinical scale assessing the 10-year fracture risk and need for lifestyle advice/reassurance, dual X-ray absorptiometry (DEXA) scanning or preventive treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21198706",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: The WHO fracture risk prediction tool (FRAX\u00ae) utilises clinical risk factors to estimate the probability of fracture over a 10-year period.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25771422",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE The WHO fracture risk prediction tool (FRAX\u00ae) utilises clinical risk factors to estimate the probability of fracture over a 10-year period.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25771422",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The FRAX score, developed by the WHO, is a free web-based clinical scale assessing the 10-year fracture risk and need for lifestyle advice/reassurance, dual X-ray absorptiometry (DEXA) scanning or preventive treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21198706",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}